A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

NCT06540833 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

370

Enrollment

INDUSTRY

Sponsor class

Conditions

Psychosis Associated With Alzheimer's Disease

Interventions

DRUG: ITI-1284
DRUG: Placebo

Sponsor

Intra-Cellular Therapies, Inc.